Combination therapy with omega-3 fatty acids plus tamsulocin and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH)

[1] Aggarwal S(2010)An overview on 5α -reductase inhibitors Steroids 75 109-153

[2] Thareja S(2010)Omega-3 fatty acids and inflammatory processes Nutrients 2 355-374

[3] Verma A(1996)Comparison of phytotherapy (Permixon) with finasteride in the treatment of BPH: a randomized international study of 1098 patients Prostate 29 231-240

[4] Bhardwaj TR(2011)Role of Inflammation in benign prostatic hyperplasia Rev Urol 13 147-150

[5] Kumar M(1999)Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis Am Pathol 155 1985-1992

[6] Calder PC(2003)Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis Eur Urol 43 164-175

[7] Carraro JC(2005)Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract (LUTS) and benign prostatic hyperplasia (BPH) symptoms Eur Urol 47 72-79

[8] Raynaud JP(2001)Combined effect of terazosin and finasteride on apoptosis, cell proliferation, and transforming growth factor-beta expression in benign prostatic hyperplasia Prostate 46 45-51

[9] Kock G(1999)Cyclooxygenase 1 and 2 isoenzymes Int J Biochem Cell Biol 31 551-557

[10] Chisolm GD(2003)Cyclooxygenase 2 and prostate carcinogenesis Cancer Lett 191 125-135

[1] Aggarwal S(2010)An overview on 5α -reductase inhibitors Steroids 75 109-153

[2] Thareja S(2010)Omega-3 fatty acids and inflammatory processes Nutrients 2 355-374

[3] Verma A(1996)Comparison of phytotherapy (Permixon) with finasteride in the treatment of BPH: a randomized international study of 1098 patients Prostate 29 231-240

[4] Bhardwaj TR(2011)Role of Inflammation in benign prostatic hyperplasia Rev Urol 13 147-150

[5] Kumar M(1999)Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis Am Pathol 155 1985-1992

[6] Calder PC(2003)Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis Eur Urol 43 164-175

[7] Carraro JC(2005)Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract (LUTS) and benign prostatic hyperplasia (BPH) symptoms Eur Urol 47 72-79

[8] Raynaud JP(2001)Combined effect of terazosin and finasteride on apoptosis, cell proliferation, and transforming growth factor-beta expression in benign prostatic hyperplasia Prostate 46 45-51

[9] Kock G(1999)Cyclooxygenase 1 and 2 isoenzymes Int J Biochem Cell Biol 31 551-557

[10] Chisolm GD(2003)Cyclooxygenase 2 and prostate carcinogenesis Cancer Lett 191 125-135